reckitt benckiser group plc - RBGPF

RBGPF

Close Chg Chg %
68.48 2.25 3.29%

Closed Market

70.73

+2.25 (3.29%)

Volume: 2.95K

Last Updated:

Apr 17, 2026, 1:40 PM EDT

Company Overview: reckitt benckiser group plc - RBGPF

RBGPF Key Data

Open

$68.17

Day Range

68.17 - 70.73

52 Week Range

60.88 - 90.71

Market Cap

$43.91B

Shares Outstanding

642.30M

Public Float

614.16M

Beta

0.54

Rev. Per Employee

N/A

P/E Ratio

10.63

EPS

$4.00

Yield

406.08%

Dividend

$1.71

EX-DIVIDEND DATE

Apr 10, 2026

SHORT INTEREST

N/A

AVERAGE VOLUME

606.59

 

RBGPF Performance

1 Week
 
4.27%
 
1 Month
 
4.93%
 
3 Months
 
-15.83%
 
1 Year
 
11.24%
 
5 Years
 
-23.81%
 

RBGPF Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings
Full Ratings ➔

About reckitt benckiser group plc - RBGPF

Reckitt Benckiser Group Plc engages in the manufacture and trade of consumer brand products including Air Wick, Calgon, Cillit Bang, Clearasil, Dettol, Durex, Enfamil, Finish, Gaviscon, Harpic, Lysol, Mortein, Mucinex, Nurofen, Nutramigen, Strepsils, Vanish, Veet, and Woolite. It operates through the following segments: Hygiene, Health, and Nutrition. The company was founded by Isaac Reckitt in 1840 and is headquartered in Slough, the United Kingdom.

RBGPF At a Glance

Reckitt Benckiser Group Plc
Turner House
Slough, Berkshire SL1 3UH
Phone 44-1753-217800 Revenue 18.72B
Industry Household/Personal Care Net Income 4.19B
Sector Consumer Non-Durables 2025 Sales Growth 3.398%
Fiscal Year-end 12 / 2026 Employees N/A
View SEC Filings

RBGPF Valuation

P/E Current 10.634
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 13.08
Price to Sales Ratio 2.937
Price to Book Ratio 5.21
Price to Cash Flow Ratio 18.16
Enterprise Value to EBITDA 12.356
Enterprise Value to Sales 3.405
Total Debt to Enterprise Value 0.178

RBGPF Efficiency

Revenue/Employee N/A
Income Per Employee N/A
Receivables Turnover 6.379
Total Asset Turnover 0.572

RBGPF Liquidity

Current Ratio 0.847
Quick Ratio 0.626
Cash Ratio 0.294

RBGPF Profitability

Gross Margin 59.775
Operating Margin 24.048
Pretax Margin 27.019
Net Margin 22.401
Return on Assets 12.889
Return on Equity 44.816
Return on Total Capital 19.371
Return on Invested Capital 22.113

RBGPF Capital Structure

Total Debt to Total Equity 108.83
Total Debt to Total Capital 52.114
Total Debt to Total Assets 33.629
Long-Term Debt to Equity 98.373
Long-Term Debt to Total Capital 47.107
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Reckitt Benckiser Group Plc - RBGPF

Collapse All in section
All values USD millions. 2022 2023 2024 2025 5-year trend
Sales/Revenue
17.80B 18.16B 18.11B 18.72B
Sales Growth
-2.19% +1.99% -0.29% +3.40%
Cost of Goods Sold (COGS) incl D&A
7.54B 7.30B 7.15B 7.53B
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
744.00M 584.23M 589.07M 657.63M
Depreciation
405.26M 451.23M 451.07M 469.17M
Amortization of Intangibles
338.74M 133.01M 138.00M 188.46M
COGS Growth
-2.37% -3.22% -2.02% +5.25%
Gross Income
10.26B 10.86B 10.95B 11.19B
Gross Income Growth
-2.05% +5.82% +0.88% +2.19%
Gross Profit Margin
+57.62% +59.79% +60.48% +59.77%
2022 2023 2024 2025 5-year trend
SG&A Expense
6.11B 6.73B 6.53B 6.69B
Research & Development
400.33M 418.91M 415.29M 416.45M
Other SG&A
5.71B 6.31B 6.11B 6.27B
SGA Growth
-8.01% +10.09% -2.96% +2.43%
Other Operating Expense
- - - -
-
Unusual Expense
167.52M 1.02B 1.31B 594.37M
EBIT after Unusual Expense
3.98B 3.10B 3.11B 3.91B
Non Operating Income/Expense
130.57M 275.96M 71.56M 1.72B
Non-Operating Interest Income
68.98M 63.40M 77.95M 57.99M
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
328.89M 395.29M 491.96M 566.69M
Interest Expense Growth
-9.42% +20.19% +24.45% +15.19%
Gross Interest Expense
328.89M 395.29M 491.96M 566.69M
Interest Capitalized
- - - -
-
Pretax Income
3.78B 2.98B 2.69B 5.06B
Pretax Income Growth
+1,169.54% -21.05% -9.92% +88.14%
Pretax Margin
+21.23% +16.44% +14.85% +27.02%
Income Tax
875.80M 936.02M 858.69M 836.86M
Income Tax - Current - Domestic
155.20M 944.72M 849.75M 1.12B
Income Tax - Current - Foreign
- 760.01M 55.94M 44.72M
Income Tax - Deferred - Domestic
(39.42M) (64.64M) (35.78M) (279.39M)
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
2.90B 2.05B 1.83B 4.22B
Minority Interest Expense
23.40M 17.40M 2.56M 6.59M
Net Income
2.88B 2.03B 1.83B 4.21B
Net Income Growth
+3,422.41% -29.44% -10.04% +130.65%
Net Margin Growth
+16.17% +11.19% +10.09% +22.51%
Extraordinaries & Discontinued Operations
- - (5.11M) (21.09M)
-
Discontinued Operations
- - (5.11M) (21.09M)
-
Net Income After Extraordinaries
2.88B 2.03B 1.82B 4.19B
Preferred Dividends
- - - -
-
Net Income Available to Common
2.88B 2.03B 1.82B 4.19B
EPS (Basic)
4.1922 2.9521 2.7101 6.4294
EPS (Basic) Growth
+6,629.91% -29.58% -8.20% +137.24%
Basic Shares Outstanding
686.67M 688.03M 672.37M 652.24M
EPS (Diluted)
4.1793 2.9456 2.7048 6.4131
EPS (Diluted) Growth
+6,609.81% -29.52% -8.17% +137.10%
Diluted Shares Outstanding
688.79M 689.55M 673.67M 653.90M
EBITDA
4.89B 4.71B 5.01B 5.16B
EBITDA Growth
+10.67% -3.66% +6.35% +2.98%
EBITDA Margin
+27.47% +25.95% +27.67% +27.56%

Reckitt Benckiser Group Plc in the News